Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3731013016 | Product containing only dapsone and pyrimethamine (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3731014010 | Dapsone and pyrimethamine only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2846671000001110 | Dapsone + Pyrimethamine (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2846681000001112 | Dapsone + Pyrimethamine | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dapsone + Pyrimethamine | Has active ingredient | Dapsone | true | Inferred relationship | Existential restriction modifier | 2 | |
| Dapsone + Pyrimethamine | Is a | Product containing dapsone and pyrimethamine | true | Inferred relationship | Existential restriction modifier | ||
| Dapsone + Pyrimethamine | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Dapsone + Pyrimethamine | Has active ingredient | Pyrimethamine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Dapsone + Pyrimethamine | Plays role | Antimalarial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Dapsone + Pyrimethamine | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only dapsone and pyrimethamine in oral dose form (medicinal product form) | Is a | True | Dapsone + Pyrimethamine | Inferred relationship | Existential restriction modifier | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet | Is a | True | Dapsone + Pyrimethamine | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR